Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares stood at 0.5 million during the latest session, with the company’s beta value hitting 1.17. At the last
In last trading session, Lineage Cell Therapeutics Inc (AMEX:LCTX) saw 2.9 million shares changing hands with its beta currently measuring 1.18. Company’s recent per share
Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.17 and has seen 1.7 million shares traded in the last trading session. The company,
Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.17 and has seen 2.87 million shares traded in the last trading session. The company,
During the last session, Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares were 6.93 million, with the beta value of the company hitting 1.16. At the
During the last session, Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares were 1.48 million, with the beta value of the company hitting 1.16. The 52-week
In the last trading session, 1.11 million shares of the Lineage Cell Therapeutics Inc (AMEX:LCTX) were traded, and its beta was 1.16. Most recently the
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s traded shares stood at 2.81 million during the last session, with the company’s beta value hitting 1.17. At the close
In the last trading session, 1.34 million Lineage Cell Therapeutics Inc (AMEX:LCTX) shares changed hands as the company’s beta touched 1.17. With the company’s per
Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.18 and has seen 8.64 million shares traded in the last trading session. The company,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
